Literature DB >> 1608685

Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature.

A M Margileth1.   

Abstract

During 24 months in an uncontrolled, retrospective study of 268 patients with cat-scratch disease (CSD), 202 were treated with 18 different antimicrobial agents. Criteria for antibiotic effectiveness were established. One or two antibiotics were taken separately for at least 3 to 5 days by 202 patients with CSD. Outcome was determined by follow-up examinations and telephone. Effectiveness of antibiotic therapy was based upon 3 or more days of therapy and clinical improvement of the patient with absence of and/or a decrease in malaise, fatigue, fever, headache, anorexia, lymphadenopathy and, in 90 patients, a declining or normal sedimentation rate. Of 18 different antimicrobials prescribed, 14 commonly used antibiotics were judged to be of little or no value in treatment of CSD. Four antimicrobials were efficacious. Efficacy of the three oral drugs in decreasing order was: rifampin 87%, ciprofloxacin 84%, trimethoprim-sulfamethoxazole 58%. Gentamicin sulfate intramuscular was 73% effective. Antibiotic therapy can be considered for patients with severe cat scratch disease. Conservative, symptomatic treatment is recommended for the majority of patients with mild or moderate CSD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608685

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  36 in total

Review 1.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  [Solitary nontuberculous mycobacterial infection of a cervical lymph node caused by Bartonella henselae (cat scratch disease)].

Authors:  M Erbe; R Lindenfelser
Journal:  Mund Kiefer Gesichtschir       Date:  2004-09-09

3.  Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human.

Authors:  Silpak Biswas; Ricardo G Maggi; Mark G Papich; Daniel Keil; Edward B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

4.  Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis.

Authors:  Camille Garnier; Guillaume Martin-Blondel; Cécile Debuisson; Damien Dubois; Alexa Debard; Lise Cuzin; Patrice Massip; Pierre Delobel; Bruno Marchou
Journal:  Infection       Date:  2015-05-23       Impact factor: 3.553

5.  Bartonella henselae is usually not viable in lymph nodes of patients with cat scratch disease.

Authors:  E Prudent; H Lepidi; G Audoly; B La Scola; P-E Fournier; S Edouard; E Angelakis; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-02       Impact factor: 3.267

Review 6.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats.

Authors:  D L Kordick; M G Papich; E B Breitschwerdt
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Cat scratch disease in the United States: an analysis of three national databases.

Authors:  L A Jackson; B A Perkins; J D Wenger
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

9.  Presumed ocular bartonellosis.

Authors:  F T Kerkhoff; J M Ossewaarde; W S de Loos; A Rothova
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

10.  Intraerythrocytic presence of Bartonella henselae.

Authors:  D L Kordick; E B Breitschwerdt
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.